NILEMDO DIN 02562782
Health Canada record
| Active ingredient(s) | BEMPEDOIC ACID 180 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AX15 BEMPEDOIC ACID |
| Original market date | 06-Feb-2026 |
| Current status date | 06-Feb-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
HLS Therapeutics Inc — licence 3-002338, currently licensed, last inspection rating C (2025-01-16).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36375 | 2025-11-14 | New Drug Submission (NDS) |
International API supply for BEMPEDOIC ACID
17 active FDA Drug Master Files.
Request a quote for NILEMDO